marketcaparena
Search

    VCEL

    Vericel Corp

    Company overview

    Market capitalization
    $2.06B
    Employees
    398
    Latest publication
    2026-09-29
    About Vericel Corp

    Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ4 20242024-12-31 · USDQ4 20232023-12-31 · USDQ4 20222022-12-31 · USDQ4 20212021-12-31 · USDQ4 20202020-12-31 · USDQ3 20202020-09-30 · USD
    Total Revenue92,918,000USD67,503,000USD75,376,000USD64,996,000USD52,694,000USD47,591,000USD45,229,000USD32,258,000USD
    Cost Of Revenue19,790,000USD17,918,000USD16,877,000USD16,489,000USD14,445,000USD13,559,000USD11,582,000USD9,787,000USD
    Gross Profit73,128,000USD49,585,000USD58,499,000USD48,507,000USD38,249,000USD34,032,000USD33,647,000USD22,471,000USD
    Research Development7,253,000USD6,318,000USD4,923,000USD4,901,000USD5,245,000USD3,924,000USD3,118,000USD2,913,000USD
    Selling General Administrative43,460,000USD39,817,000USD35,097,000USD30,875,000USD26,919,000USD25,967,000USD18,240,000USD16,041,000USD
    Total Operating Expenses50,713,000USD46,135,000USD40,020,000USD35,776,000USD32,164,000USD29,891,000USD21,358,000USD18,954,000USD
    Operating Income22,415,000USD3,450,000USD18,479,000USD12,731,000USD6,085,000USD4,141,000USD12,289,000USD3,517,000USD
    Interest Income1,885,000USD1,808,000USD1,560,000USD1,436,000USD763,000USD61,000USD117,000USD121,000USD
    Interest Expense162,000USD158,000USD154,000USD156,000USD223,000USD1,000USD1,000USD2,000USD
    Net Interest Income1,723,000USD1,650,000USD1,406,000USD1,280,000USD540,000USD60,000USD116,000USD119,000USD
    Income Before Tax24,102,000USD5,074,000USD19,955,000USD14,093,000USD6,622,000USD4,208,000USD12,400,000USD3,618,000USD
    Income Tax Expense859,000USD—148,000USD1,100,000USD700,000USD-326,000USD180,000USD-101,000USD
    Net Income23,243,000USD5,074,000USD19,807,000USD12,993,000USD5,922,000USD4,534,000USD12,220,000USD3,618,000USD
    Net Income From Continuing Ops23,243,000USD5,074,000USD19,807,000USD12,993,000USD5,922,000USD4,535,000USD12,220,000USD3,618,000USD
    Ebit24,264,000USD5,232,000USD20,109,000USD14,249,000USD6,845,000USD4,209,000USD12,401,000USD3,620,000USD
    Ebitda27,530,000USD8,176,000USD21,586,000USD15,398,000USD7,884,000USD4,989,000USD13,135,000USD4,190,000USD
    Depreciation And Amortization3,266,000USD2,944,000USD1,477,000USD1,149,000USD1,039,000USD780,000USD734,000USD570,000USD
    Reconciled Depreciation3,088,000USD2,944,000USD1,477,000USD1,149,000USD1,039,000USD780,000USD-2,578,000USD2,279,000USD
    Total Other Income Expense Net1,687,000USD1,624,000USD1,476,000USD1,362,000USD537,000USD67,000USD111,000USD101,000USD
    Tax Provision——148,000USD1,100,000USD700,000USD-326,000USD180,000USD—
    Non Operating Income Net Other————760,000USD69,000USD119,000USD103,000USD
    Net Income Applicable To Common Shares————5,922,000USD4,535,000USD12,220,000USD3,618,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20202020-12-31 · USDFY 20102010-12-31 · USDFY 20092009-12-31 · USDFY 20052005-12-31 · USDFY 20042004-12-31 · USDFY 20032003-12-31 · USD
    Total Revenue276,259,000USD237,224,000USD124,179,000USD89,000USD182,000USD909,000USD1,302,000USD844,000USD
    Cost Of Revenue70,660,000USD65,117,000USD39,951,000USD34,000USD112,000USD148,000USD280,000USD893,000USD
    Gross Profit205,599,000USD172,107,000USD84,228,000USD55,000USD70,000USD761,000USD1,022,000USD-49,000USD
    Research Development27,563,000USD24,797,000USD13,020,000USD12,658,000USD11,289,000USD7,206,000USD6,289,000USD5,647,000USD
    Selling General Administrative166,992,000USD142,791,000USD68,836,000USD5,201,000USD4,950,000USD5,972,000USD5,390,000USD4,017,000USD
    Total Operating Expenses194,555,000USD167,588,000USD81,856,000USD17,859,000USD16,239,000USD13,178,000USD11,679,000USD9,664,000USD
    Operating Income11,044,000USD4,519,000USD2,372,000USD-17,804,000USD-16,169,000USD-12,417,000USD-10,657,000USD-9,713,000USD
    Interest Income7,007,000USD6,410,000USD691,000USD—————
    Interest Expense1,556,000USD614,000USD6,000USD40,000USD73,000USD0USD0USD0USD
    Net Interest Income6,377,000USD5,796,000USD685,000USD—————
    Income Before Tax17,377,000USD10,510,000USD3,044,000USD-17,729,000USD-15,946,000USD-12,405,000USD-10,488,000USD-9,579,000USD
    Income Tax Expense859,000USD148,000USD180,000USD-115,000USD-296,000USD-618,000USD-169,000USD-134,000USD
    Tax Provision859,000USD148,000USD180,000USD—————
    Net Income16,518,000USD10,362,000USD2,864,000USD-17,729,000USD-15,946,000USD-11,811,000USD-10,488,000USD-9,579,000USD
    Net Income From Continuing Ops16,518,000USD10,362,000USD2,864,000USD—————
    Ebit18,933,000USD11,124,000USD3,050,000USD-30,740,000USD-18,508,000USD-17,832,000USD-12,542,000USD-10,482,000USD
    Ebitda30,294,000USD16,628,000USD5,433,000USD-30,148,000USD-17,804,000USD-17,733,000USD-12,417,000USD-10,363,000USD
    Depreciation And Amortization11,361,000USD5,504,000USD2,383,000USD592,000USD704,000USD99,000USD125,000USD119,000USD
    Reconciled Depreciation11,544,000USD5,504,000USD2,383,000USD—————
    Total Other Income Expense Net6,333,000USD5,991,000USD672,000USD-20,372,000USD1,858,000USD1,258,000USD606,000USD169,000USD
    Non Operating Income Net Other——685,000USD—————
    Net Income Applicable To Common Shares——2,864,000USD—————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets485,627,000USD487,969,000USD453,274,000USD435,608,000USD424,587,000USD432,722,000USD390,405,000USD376,839,000USD
    Intangible Assets5,469,000USD5,625,000USD5,781,000USD5,938,000USD6,094,000USD6,250,000USD6,406,000USD6,563,000USD
    Other Current Assets7,990,000USD7,744,000USD8,006,000USD6,575,000USD14,733,000USD17,816,000USD24,551,000USD31,995,000USD
    Total Liab129,396,000USD133,329,000USD131,416,000USD128,799,000USD129,100,000USD140,755,000USD132,933,000USD133,862,000USD
    Total Stockholder Equity356,231,000USD354,640,000USD321,858,000USD306,809,000USD295,487,000USD291,967,000USD257,472,000USD242,977,000USD
    Other Current Liab13,967,000USD19,236,000USD16,402,000USD14,522,000USD11,534,000USD17,181,000USD14,343,000USD12,856,000USD
    Common Stock738,998,000USD730,662,000USD721,140,000USD711,240,000USD699,412,000USD684,778,000USD669,735,000USD654,971,000USD
    Capital Stock738,998,000USD730,662,000USD721,140,000USD711,240,000USD699,412,000USD684,778,000USD669,735,000USD654,971,000USD
    Retained Earnings-382,599,000USD-376,297,000USD-399,540,000USD-404,614,000USD-404,061,000USD-392,815,000USD-412,622,000USD-411,721,000USD
    Cash109,295,000USD100,092,000USD100,403,000USD80,532,000USD73,490,000USD74,520,000USD53,681,000USD50,291,000USD
    Cash And Short Term Investments145,340,000USD137,499,000USD135,380,000USD116,881,000USD112,902,000USD116,213,000USD101,734,000USD102,508,000USD
    Total Current Assets244,064,000USD247,437,000USD221,967,000USD204,577,000USD197,640,000USD212,777,000USD190,520,000USD197,386,000USD
    Total Current Liabilities47,155,000USD49,149,000USD45,582,000USD41,132,000USD39,448,000USD50,286,000USD41,346,000USD43,863,000USD
    Net Debt-14,754,000USD-1,827,000USD-2,397,000USD19,232,000USD25,477,000USD24,330,000USD43,782,000USD45,301,000USD
    Short Term Debt14,179,000USD14,085,000USD13,845,000USD13,753,000USD11,163,000USD9,257,000USD6,119,000USD5,791,000USD
    Short Long Term Debt Total94,541,000USD98,265,000USD98,006,000USD99,764,000USD98,967,000USD98,850,000USD97,463,000USD95,592,000USD
    Long Term Investments65,284,000USD61,395,000USD49,664,000USD47,400,000USD43,342,000USD39,880,000USD32,895,000USD26,120,000USD
    Short Term Investments36,045,000USD37,407,000USD34,977,000USD36,349,000USD39,412,000USD41,693,000USD48,053,000USD52,217,000USD
    Net Receivables72,383,000USD84,634,000USD60,426,000USD64,290,000USD52,899,000USD61,375,000USD48,479,000USD47,996,000USD
    Inventory18,351,000USD17,560,000USD18,155,000USD16,831,000USD17,106,000USD17,373,000USD15,756,000USD14,887,000USD
    Accounts Payable19,009,000USD15,828,000USD15,335,000USD12,857,000USD16,751,000USD23,848,000USD20,884,000USD25,216,000USD
    Property Plant Equipment Net170,522,000USD173,171,000USD175,467,000USD177,246,000USD177,010,000USD173,259,000USD159,974,000USD146,106,000USD
    Property Plant Equipment Gross205,183,000USD204,721,000USD204,184,000USD203,175,000USD200,269,000USD200,158,000USD185,552,000USD170,701,000USD
    Accumulated Other Comprehensive Income-168,000USD275,000USD258,000USD183,000USD136,000USD4,000USD359,000USD-273,000USD
    Common Stock Shares Outstanding50,773,000shares52,071,000shares51,908,000shares50,368,000shares49,905,000shares52,210,000shares49,085,000shares48,686,000shares
    Non Current Assets Total241,563,000USD240,532,000USD231,307,000USD231,031,000USD226,947,000USD219,945,000USD199,885,000USD179,453,000USD
    Non Current Liabilities Total82,241,000USD84,180,000USD85,834,000USD87,667,000USD89,652,000USD90,469,000USD91,587,000USD89,999,000USD
    Non Current Liabilities Other1,879,000USD1,896,000USD1,673,000USD1,656,000USD1,848,000USD876,000USD243,000USD198,000USD
    Non Currrent Assets Other288,000USD341,000USD395,000USD447,000USD501,000USD556,000USD610,000USD664,000USD
    Net Working Capital196,909,000USD198,288,000USD176,385,000USD163,445,000USD158,192,000USD162,491,000USD149,174,000USD153,523,000USD
    Unclassified Non Current Liabilities80,362,000USD82,284,000USD84,161,000USD86,011,000USD87,804,000USD89,593,000USD91,344,000USD89,801,000USD
    Unclassified Equity-738,998,000USD-730,662,000USD-721,140,000USD-711,240,000USD-699,412,000USD-684,778,000USD-669,735,000USD-654,971,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets487,969,000USD432,722,000USD353,657,000USD273,003,000USD243,705,000USD205,608,000USD153,238,000USD118,689,000USD
    Intangible Assets5,625,000USD6,250,000USD6,875,000USD7,500,000USD————
    Other Current Assets7,744,000USD17,816,000USD24,631,000USD4,803,000USD4,246,000USD3,893,000USD2,953,000USD2,847,000USD
    Total Liab133,329,000USD140,755,000USD127,705,000USD80,731,000USD73,243,000USD71,348,000USD42,147,000USD16,458,000USD
    Total Stockholder Equity354,640,000USD291,967,000USD225,952,000USD192,272,000USD170,462,000USD134,260,000USD111,091,000USD102,231,000USD
    Other Current Liab19,236,000USD17,181,000USD17,215,000USD16,231,000USD14,045,000USD11,293,000USD7,948,000USD7,684,000USD
    Common Stock730,662,000USD684,778,000USD629,229,000USD593,245,000USD553,902,000USD510,061,000USD489,749,000USD471,180,000USD
    Capital Stock730,662,000USD684,778,000USD629,229,000USD593,245,000USD553,902,000USD510,061,000USD489,749,000USD471,180,000USD
    Retained Earnings-376,297,000USD-392,815,000USD-403,177,000USD-399,995,000USD-383,286,000USD-375,815,000USD-378,679,000USD-369,014,000USD
    Cash100,092,000USD74,520,000USD69,088,000USD51,067,000USD68,330,000USD33,620,000USD26,889,000USD18,286,000USD
    Cash And Short Term Investments137,499,000USD116,213,000USD109,557,000USD119,538,000USD103,398,000USD75,807,000USD69,718,000USD82,924,000USD
    Total Current Assets247,437,000USD212,777,000USD205,631,000USD186,866,000USD158,462,000USD123,560,000USD111,655,000USD112,783,000USD
    Total Current Liabilities49,149,000USD50,286,000USD45,749,000USD37,463,000USD26,052,000USD22,483,000USD19,795,000USD14,792,000USD
    Net Debt-1,827,000USD24,330,000USD18,955,000USD-3,497,000USD-18,148,000USD19,680,000USD965,000USD-18,286,000USD
    Short Term Debt14,085,000USD9,257,000USD6,187,000USD4,302,000USD2,991,000USD4,435,000USD5,502,000USD—
    Short Long Term Debt Total98,265,000USD98,850,000USD88,043,000USD47,570,000USD50,182,000USD53,300,000USD27,854,000USD—
    Long Term Investments61,395,000USD39,880,000USD25,283,000USD19,962,000USD25,687,000USD24,099,000USD9,247,000USD—
    Short Term Investments37,407,000USD41,693,000USD40,469,000USD68,471,000USD35,068,000USD42,187,000USD42,829,000USD64,638,000USD
    Net Receivables84,634,000USD61,375,000USD58,356,000USD46,539,000USD37,437,000USD34,504,000USD32,168,000USD23,454,000USD
    Inventory17,560,000USD17,373,000USD13,087,000USD15,986,000USD13,381,000USD9,356,000USD6,816,000USD3,558,000USD
    Accounts Payable15,828,000USD23,848,000USD22,347,000USD16,930,000USD9,016,000USD6,755,000USD6,345,000USD7,108,000USD
    Property Plant Equipment Net173,171,000USD173,259,000USD115,097,000USD57,372,000USD59,028,000USD57,738,000USD32,247,000USD5,906,000USD
    Property Plant Equipment Gross204,721,000USD200,158,000USD137,303,000USD57,372,000USD59,028,000USD30,000USD32,247,000USD5,906,000USD
    Accumulated Other Comprehensive Income275,000USD4,000USD-100,000USD-978,000USD-154,000USD14,000USD21,000USD-39,000USD
    Common Stock Shares Outstanding52,071,000shares51,679,000shares47,590,000shares47,130,000shares46,472,000shares47,282,000shares44,180,000shares40,242,000shares
    Non Current Assets Total240,532,000USD219,945,000USD148,026,000USD86,137,000USD85,243,000USD82,048,000USD41,583,000USD5,906,000USD
    Non Current Liabilities Total84,180,000USD90,469,000USD81,956,000USD43,268,000USD47,191,000USD48,865,000USD22,352,000USD1,666,000USD
    Non Current Liabilities Other1,896,000USD876,000USD100,000USD43,268,000USD47,191,000USD48,865,000USD22,352,000USD—
    Non Currrent Assets Other341,000USD556,000USD771,000USD1,303,000USD528,000USD211,000USD89,000USD5,906,000USD
    Net Working Capital198,288,000USD162,491,000USD159,882,000USD149,403,000USD132,410,000USD101,077,000USD91,860,000USD97,991,000USD
    Unclassified Non Current Liabilities82,284,000USD89,593,000USD81,856,000USD—————
    Unclassified Equity-730,662,000USD-684,778,000USD-629,229,000USD-593,245,000USD-553,902,000USD-510,061,000USD-489,749,000USD-471,076,000USD
    Other Assets——1USD1,303,000USD528,000USD57,919,000USD89,000USD—
    Current Deferred Revenue——3,118,000USD—14,045,000USD11,293,000USD7,948,000USD—
    Unclassified Current Liabilities——-3,118,000USD—-14,045,000USD-11,293,000USD-7,948,000USD—
    Net Tangible Assets———184,772,000USD170,462,000USD134,260,000USD111,091,000USD102,231,000USD
    Unclassified Non Current Assets———-1,303,000USD—-57,919,000USD—-5,906,000USD
    Other Liab————44,000USD——1,502,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-6,302,000USD23,243,000USD5,074,000USD-553,000USD-11,246,000USD19,807,000USD-901,000USD-4,682,000USD
    Depreciation3,267,000USD3,266,000USD2,944,000USD2,654,000USD2,686,000USD1,477,000USD784,000USD1,323,000USD
    Stock Based Compensation11,294,000USD8,423,000USD8,699,000USD10,140,000USD11,505,000USD7,917,000USD9,224,000USD9,520,000USD
    Other Non Cash Items1,586,000USD2,335,000USD1,278,000USD1,498,000USD1,321,000USD1,469,000USD2,087,000USD1,508,000USD
    Change To Account Receivables12,251,000USD-24,208,000USD3,864,000USD-11,391,000USD8,476,000USD-12,896,000USD-483,000USD1,938,000USD
    Change To Inventory-964,000USD-448,000USD-1,324,000USD275,000USD267,000USD-1,617,000USD-869,000USD-1,330,000USD
    Change In Working Capital6,538,000USD-22,253,000USD4,087,000USD-5,525,000USD2,334,000USD-8,428,000USD-1,010,000USD10,866,000USD
    Total Cash From Operating Activities16,383,000USD15,014,000USD22,082,000USD8,214,000USD6,600,000USD22,242,000USD10,184,000USD18,535,000USD
    Capital Expenditures-1,257,000USD-14,212,000USD-2,630,000USD14,212,000USD-14,212,000USD-13,787,000USD30,778,000USD-16,761,000USD
    Free Cash Flow15,126,000USD802,000USD19,452,000USD22,426,000USD-7,612,000USD8,455,000USD40,962,000USD1,774,000USD
    Investments-2,944,000USD-14,203,000USD-3,377,000USD-9,028,000USD-15,142,000USD-14,651,000USD-21,212,000USD-17,719,000USD
    Total Cashflows From Investing Activities-4,201,000USD-16,390,000USD-3,377,000USD-9,028,000USD-15,142,000USD-14,651,000USD-21,212,000USD-17,719,000USD
    Total Cash From Financing Activities-2,979,000USD1,065,000USD1,166,000USD1,641,000USD3,198,000USD7,108,000USD5,524,000USD4,296,000USD
    Issuance Of Capital Stock1,563,000USD1,255,000USD1,482,000USD1,788,000USD9,409,000USD7,261,000USD5,795,000USD4,434,000USD
    Change In Cash9,203,000USD-311,000USD19,871,000USD827,000USD-5,344,000USD14,699,000USD-5,504,000USD5,112,000USD
    Begin Period Cash Flow100,092,000USD100,403,000USD80,532,000USD79,705,000USD85,049,000USD70,350,000USD75,854,000USD70,742,000USD
    End Period Cash Flow109,295,000USD100,092,000USD100,403,000USD80,532,000USD79,705,000USD85,049,000USD70,350,000USD75,854,000USD
    Other Cashflows From Investing Activities-2,944,000USD12,025,000USD-2,630,000USD-22,345,000USD——-50,187,000USD-16,761,000USD
    Other Cashflows From Financing Activities-4,542,000USD-190,000USD-316,000USD-147,000USD-6,211,000USD-153,000USD-271,000USD-138,000USD
    Unclassified Investing Cash Flow2,944,000USD—5,260,000USD8,133,000USD14,212,000USD13,787,000USD19,409,000USD33,522,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income16,518,000USD10,362,000USD-3,182,000USD-16,709,000USD-7,471,000USD2,864,000USD-9,665,000USD-8,137,000USD
    Depreciation11,361,000USD5,504,000USD4,632,000USD3,981,000USD2,965,000USD2,383,000USD1,744,000USD1,426,000USD
    Stock Based Compensation38,767,000USD36,495,000USD32,325,000USD37,183,000USD34,322,000USD13,843,000USD13,179,000USD7,223,000USD
    Other Non Cash Items6,621,000USD6,252,000USD5,500,000USD3,720,000USD4,429,000USD4,445,000USD2,787,000USD3,108,000USD
    Change To Account Receivables-23,259,000USD-3,019,000USD-11,817,000USD-9,102,000USD-2,933,000USD-2,336,000USD-8,714,000USD-5,184,000USD
    Change To Inventory-1,230,000USD-4,286,000USD2,899,000USD-2,605,000USD-4,025,000USD-2,540,000USD-3,258,000USD235,000USD
    Change In Working Capital-21,357,000USD-450,000USD-3,964,000USD-11,209,000USD-6,154,000USD-6,374,000USD-14,660,000USD-4,032,000USD
    Total Cash From Operating Activities51,910,000USD58,163,000USD35,311,000USD17,687,000USD29,040,000USD17,572,000USD-7,183,000USD-412,000USD
    Capital Expenditures-27,162,000USD-63,974,000USD-27,513,000USD-7,596,000USD-7,915,000USD-2,626,000USD-2,616,000USD-2,678,000USD
    Free Cash Flow24,748,000USD-5,811,000USD7,798,000USD10,091,000USD21,125,000USD14,946,000USD-9,799,000USD-3,090,000USD
    Investments-16,775,000USD-79,034,000USD-16,771,000USD-36,206,000USD4,414,000USD-14,534,000USD13,231,000USD-64,349,000USD
    Total Cashflows From Investing Activities-43,937,000USD-79,034,000USD-3,130,000USD-36,206,000USD-3,501,000USD-17,160,000USD10,615,000USD-67,027,000USD
    Total Cash From Financing Activities7,070,000USD19,054,000USD3,618,000USD1,045,000USD9,171,000USD6,441,000USD5,260,000USD58,863,000USD
    Issuance Of Capital Stock13,934,000USD24,516,000USD5,226,000USD3,652,000USD11,184,000USD6,632,000USD0USD74,389,000USD
    Change In Cash15,043,000USD-1,817,000USD35,799,000USD-17,474,000USD34,710,000USD6,853,000USD8,692,000USD-8,576,000USD
    Begin Period Cash Flow85,049,000USD86,866,000USD51,067,000USD68,541,000USD33,831,000USD26,978,000USD18,286,000USD26,862,000USD
    End Period Cash Flow100,092,000USD85,049,000USD86,866,000USD51,067,000USD68,541,000USD33,831,000USD26,978,000USD18,286,000USD
    Other Cashflows From Investing Activities-27,162,000USD-63,974,000USD-27,513,000USD-7,596,000USD-7,915,000USD-2,626,000USD-2,616,000USD-2,678,000USD
    Other Cashflows From Financing Activities-6,864,000USD-5,462,000USD-2,382,000USD-2,607,000USD-2,013,000USD-191,000USD-26,000USD7,077,000USD
    Unclassified Investing Cash Flow27,162,000USD127,948,000USD68,667,000USD15,192,000USD7,915,000USD2,626,000USD2,616,000USD2,678,000USD
    Change To Liabilities———3,582,000USD4,243,000USD3,393,000USD-70,000USD2,431,000USD
    Net Borrowings———-1,076,000USD———-18,242,000USD
    Sale Purchase Of Stock———3,652,000USD11,184,000USD6,632,000USD5,286,000USD77,105,000USD
    Cash And Cash Equivalents Changes———-17,474,000USD34,710,000USD6,853,000USD8,692,000USD-8,576,000USD
    Unclassified Financing Cash Flow———1,076,000USD———-7,077,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2020Quarterly · 2020-03-31ProductBiopsy Kits466,000USD0001628280-20-007473
    Q1 2020Quarterly · 2020-03-31ProductEpicel6,392,000USD0001628280-20-007473
    Q1 2020Quarterly · 2020-03-31ProductImplants18,613,000USD0001628280-20-007473
    Q1 2020Quarterly · 2020-03-31ProductOther1,207,000USD0001628280-20-007473
    FY 2019Yearly · 2019-12-31ProductBiopsy Kits2,243,000USD0001628280-21-003081
    FY 2019Yearly · 2019-12-31ProductEpicel26,230,000USD0001628280-21-003081
    FY 2019Yearly · 2019-12-31ProductImplants88,723,000USD0001628280-21-003081
    FY 2019Yearly · 2019-12-31ProductOther654,000USD0001628280-21-003081
    Q2 2019Quarterly · 2019-06-30ProductBiopsy Kits557,000USD0001628280-20-011753
    Q2 2019Quarterly · 2019-06-30ProductEpicel5,328,000USD0001628280-20-011753
    Q2 2019Quarterly · 2019-06-30ProductImplants20,179,000USD0001628280-20-011753
    Q2 2019Quarterly · 2019-06-30ProductOther87,000USD0001628280-20-011753
    Q1 2019Quarterly · 2019-03-31ProductBiopsy Kits542,000USD0001628280-20-007473
    Q1 2019Quarterly · 2019-03-31ProductEpicel5,227,000USD0001628280-20-007473
    Q1 2019Quarterly · 2019-03-31ProductImplants16,078,000USD0001628280-20-007473
    FY 2018Yearly · 2018-12-31ProductBiopsy Kits1,997,000USD0001628280-20-002229
    FY 2018Yearly · 2018-12-31ProductEpicel23,116,000USD0001628280-20-002229
    FY 2018Yearly · 2018-12-31ProductImplants65,926,000USD0001628280-20-002229
    FY 2018Yearly · 2018-12-31ProductOther Revenue0USD0001628280-20-002229
    Q3 2018Quarterly · 2018-09-30ProductBiopsy Kits488,000USD0001628280-19-013312
    Q3 2018Quarterly · 2018-09-30ProductEpicel6,035,000USD0001628280-19-013312
    Q3 2018Quarterly · 2018-09-30ProductImplants15,836,000USD0001628280-19-013312
    Q3 2018Quarterly · 2018-09-30ProductOther125,000USD0001628280-19-013312
    Q2 2018Quarterly · 2018-06-30ProductBiopsy Kits468,000USD0001628280-19-010077
    Q2 2018Quarterly · 2018-06-30ProductEpicel4,886,000USD0001628280-19-010077
    Q2 2018Quarterly · 2018-06-30ProductImplants13,708,000USD0001628280-19-010077
    Q1 2018Quarterly · 2018-03-31ProductBiopsy Kits436,000USD0001628280-19-006102
    Q1 2018Quarterly · 2018-03-31ProductEpicel5,972,000USD0001628280-19-006102
    Q1 2018Quarterly · 2018-03-31ProductImplants11,757,000USD0001628280-19-006102
    FY 2017Yearly · 2017-12-31ProductBiopsy Kits1,764,000USD0001628280-20-002229
    FY 2017Yearly · 2017-12-31ProductEpicel18,858,000USD0001628280-20-002229
    FY 2017Yearly · 2017-12-31ProductImplants42,488,000USD0001628280-20-002229
    FY 2017Yearly · 2017-12-31ProductOther Revenue1,164,000USD0001628280-20-002229
    FY 2016Yearly · 2016-12-31ProductBiopsy Kits1,545,000USD0001628280-19-002007
    FY 2016Yearly · 2016-12-31ProductEpicel15,512,000USD0001628280-19-002007
    FY 2016Yearly · 2016-12-31ProductImplants37,326,000USD0001628280-19-002007

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.